Argus Research analyst Jasper Hellweg upgrades Biogen (NASDAQ:BIIB) from Hold to Buy.
Telsey Advisory Group Maintains Market Perform on Under Armour, Lowers Price Target to $8
Telsey Advisory Group analyst Cristina Fernandez maintains Under Armour (NYSE:UAA) with a Market Perform and lowers the price target from $12 to $8.